Neuronetics (STIM) Accumulated Expenses (2017 - 2026)

Neuronetics (STIM) has reported Accumulated Expenses for 10 consecutive years, with $600000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Accumulated Expenses rose 14.07% year-over-year to $600000.0; the TTM figure through Mar 2026 stood at $600000.0 (up 14.07% YoY), while the FY2025 annual figure was $724000.0, down 90.9% from the prior year.
• Accumulated Expenses declined to $600000.0 in Q1 2026 per STIM's latest filing, from $724000.0 in the prior quarter.
• Across five years, Accumulated Expenses topped out at $11.2 million in Q4 2022 and bottomed at $246000.0 in Q3 2022.
• Historically, Accumulated Expenses has averaged $4.3 million across 5 years, with a median of $1.8 million in 2023.
• Annual changes were most pronounced in 2023 — Accumulated Expenses surged 3980.08% — and 2024, when it tumbled 96.04%.
• Neuronetics' Accumulated Expenses stood at $11.2 million in 2022, then sank by 84.29% to $1.8 million in 2023, then jumped by 351.82% to $8.0 million in 2024, then sank by 90.9% to $724000.0 in 2025, then declined by 17.13% to $600000.0 in 2026.
• Business Quant data shows STIM's Accumulated Expenses at $600000.0 in Q1 2026, $724000.0 in Q4 2025, and $9.7 million in Q3 2025.